Sun Pharma Advanced Research Co (NSE:SPARC) Gross Property, Plant and Equipment: ₹1,432 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SPARC Sun Pharma Advanced Research Co Ltd NSE:SPARC
48 GF Score
Price ₹213.17
GF Value ₹83.48
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co Gross Property, Plant and Equipment?

Sun Pharma Advanced Research Co NSE:SPARC +2.01% 48 Gross Property, Plant and Equipment is ₹1,432 Mil as of Mar. 2026. GuruFocus rates NSE:SPARC with a GF Score™ of 48/100 and a GF Value™ of ₹83.48 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Sun Pharma Advanced Research Co's quarterly gross PPE declined from Sep. 2025 (₹915 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,432 Mil).

Sun Pharma Advanced Research Co's annual gross PPE stayed the same from Mar. 2024 (₹1,576 Mil) to Mar. 2025 (₹1,575 Mil) but then declined from Mar. 2025 (₹1,575 Mil) to Mar. 2026 (₹1,432 Mil).


Sun Pharma Advanced Research Co  (NSE:SPARC) Gross Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


Sun Pharma Advanced Research Co Gross Property, Plant and Equipment Related Terms


Sun Pharma Advanced Research Co Gross Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for Sun Pharma Advanced Research Co's Gross Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co Gross Property, Plant and Equipment Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Gross Property, Plant and Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,362.64 1,486.86 1,576.40 1,574.81 1,431.84

Sun Pharma Advanced Research Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,574.81 0.00 914.80 0.00 1,431.84
NSE:SPARC
48GF Score
Sun Pharma Advanced Research Co Ltd NSE:SPARC
Gross Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharma Advanced Research Co Gross Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the company. Fixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Gross Property, Plant and Equipment of ₹1,432 Mil mean?
Sun Pharma Advanced Research Co (NSE:SPARC) has a Gross Property, Plant and Equipment of ₹1,432 Mil as of Mar. 2026. The total gross property, plant and equipment assets recorded on a company's balance sheet. View historical data on Sun Pharma Advanced Research Co and its competitors.
Is Sun Pharma Advanced Research Co's Gross Property, Plant and Equipment too high?
Sun Pharma Advanced Research Co's current Gross Property, Plant and Equipment is ₹1,432 Mil. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's Gross Property, Plant and Equipment compare to ZTS?
Sun Pharma Advanced Research Co's Gross Property, Plant and Equipment of ₹1,432 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Property, Plant and Equipment for a Drug Manufacturers company?
A good Gross Property, Plant and Equipment depends on the Drug Manufacturers industry context. However, Gross Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Property, Plant and Equipment mean?
A high Gross Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total gross property, plant and equipment assets recorded on a company's balance sheet. View historical data on Sun Pharma Advanced Research Co and its competitors. Sun Pharma Advanced Research Co's current Gross Property, Plant and Equipment is ₹1,432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (NSE:SPARC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹83.48, compared to a current price of ₹213.17 — trading 155.4% above its estimated fair value. The current Gross Property, Plant and Equipment is ₹1,432 Mil. Sun Pharma Advanced Research Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Property, Plant and Equipment calculated?
Gross Property, Plant and Equipment is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (NSE:SPARC), the current Gross Property, Plant and Equipment is ₹1,432 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be overvalued. The current stock price of ₹213.17 is trading 155.4% above its estimated GF Value™ of ₹83.48. GuruFocus considers Sun Pharma Advanced Research Co to be Significantly Overvalued.

Key valuation signals for NSE:SPARC:

  • Gross Property, Plant and Equipment: ₹1,432 Mil
  • GF Value™: ₹83.48 vs. price of ₹213.17 (155.4% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sun Pharma Advanced Research Co Business Description

Other Exchanges 532872:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
48GF Score

Get the complete analysis for NSE:SPARC

Gross Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹213.17
Price
₹83.48
GF Value